Shares of HIMS experienced a dramatic drop today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by over 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it coul